van der Linde D, Konings EE, Slager MA et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011;58:2241–7.
Australian and New Zealand Intensive Care SocietyReport of the Australian and New Zealand Paediatric Intensive Care Registry (ANZPIC). Brisbane, Australia: Centre for Outcome and Resource Evaluation, 2014.
Australian Institute of Health and WelfareA Picture of Australia’s Children 2012. Cat. No. PHE 167. Canberra, Australia: AIHW, 2012.
Australian Institute of Health and WelfareAustralian Burden of Disease Study: Impact and causes of illness and death in Australia 2011Australian Burden of Disease Study Series No. 3. Cat. No. BOD 4. Canberra, Australia: AIHW, 2016.
Celermajer D, Strange G, Cordina R et al. Congenital heart disease requires a lifetime continuum of care: a call for a Regional Registry. Heart Lung Circ 2016;25:750–4.
Gilboa SM, Devine OJ, Kucik JE et al. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation 2016;134:101–9.
Helm BM & Freeze SL. Genetic evaluation and use of chromosome microarray in patients with isolated heart defects: benefits and challenges of a new model in cardiovascular care. Front Cardiovasc Med 2016;3:19.
Blue GM, Kirk EP, Giannoulatou E et al. Advances in the genetics of congenital heart disease. J Am Coll Cardiol 2017;69:859–70.
Blue GM, Kirk EP, Giannoulatou E et al. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease. J Am Coll Cardiol 2014;64:2498–506.
Jia Y, Louw JJ, Breckpot J et al. The diagnostic value of next generation sequencing in familial nonsyndromic congenital heart defects. Am J Med Genet A 2015;167:1822–9.
Zaidi S, Choi M, Wakimoto H et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 2013;498:220–3.
Homsy J, Zaidi S, Shen Y et al. De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science 2015;350:1262–6.
Pierpont ME, Basson CT, Benson DW Jr. et al. Genetic basis for congenital heart defects: current knowledge. A scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young, endorsed by the American Academy of Pediatrics. Circulation 2007;115:3015–38.
Parrott A & Ware SM. The role of the geneticist and genetic counselor in an ACHD clinic. Prog Ped Cardiol 2012;34:15–20.
Kirk EP, Sunde M, Costa MW et al. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Human Genet 2007;81:280–91.
Costa MW, Guo G, Wolstein O et al. Functional characterization of a novel mutation in NKX2-5 associated with congenital heart isease and adult-onset cardiomyopathy. Circ Cardiovasc Genet 2013;6:238–47.
Zhang XL, Qiu XB, Yuan F et al. TBX5 loss-of-function mutation contributes to familial dilated cardiomyopathy. Biochem Biophys Res Commun 2015;459:166–71.
Smith AH, Flack EC, Borgman KY et al. A common angiotensin-converting enzyme polymorphism and preoperative angiotensin-converting enzyme inhibition modify risk of tachyarrhythmias after congenital heart surgery. Heart Rhythm 2014;11:637–43.
Zhang H, Gong DX, Zhang YJ, Li SJ & Hu S. Effect of mitochondrial aldehyde dehydrogenase-2 genotype on cardioprotection in patients with congenital heart disease. Eur Heart J 2012;33:1606–14.
Carey AS, Liang L, Edwards J et al. Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circ Cardiovasc Genet 2013;6:444–51.
Kim DS, Kim JH, Burt AA et al. Burden of potentially pathologic copy number variants is higher in children with isolated congenital heart disease and significantly impairs covariate-adjusted transplant-free survival. J Thorac Cardiovasc Surg 2016;151:1147–1151.
Green RC, Berg JS, Grody WW et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565–74.
American College of Medical Genetics and Genomics (ACMG) Board of Directors. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet Med 2014;17:68–9.
Kasparian NA, Fidock B, Sholler GF et al. Parents’ perceptions of genetics services for congenital heart disease: the role of demographic, clinical, and psychological factors in determining service attendance. Genet Med 2014;16:460–8.
Fitzgerald-Butt SM, Klima J, Kelleher K, Chisolm D & McBride KL. Genetic knowledge and attitudes of parents of children with congenital heart defects. Am J Med Genet A 2014;164:3069–75.
Blue GM, Kasparian NA, Sholler GF, Kirk EP & Winlaw DS. Genetic counselling in parents of children with congenital heart disease significantly improves knowledge about causation and enhances psychosocial functioning. Int J Cardiol 2015;178:124–30.
Clark MD, Determann D, Petrou S, Moro D & de Bekker-Grob EW. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics 2014;32:883–902.
Mühlbacher A & Johnson FR. Choice experiments to quantify preferences for health and healthcare: State of the practice. Appl Health Econ Health Policy 2016;14:253–66.
Discrete Choice Experiments [computer program]. http://maths.science.uts.edu.au/maths/wiki/SPExpts.Department of Mathematical Sciences, University of Technology, Sydney, Australia, 2007.
Australian Bureau of Statistics. Survey of Income and Housing. 2007–08; http://www.abs.gov.au/ausstats/abs@.nsf/1020492cfcd63696ca2568a1002477b5/5f4bb49c975c64c9ca256d6b00827adb!OpenDocument. Accessed 12 February 2010.
Hole A. Fitting mixed logit models by using maximum simulated likelihood. Stata J 2007;7:388–401.
Peacock S, Apicella C, Andrews L et al. A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services. Brit J Cancer 2006;95:1448–53.
Kasparian NA, Winlaw DS & Sholler GF. ‘Congenital heart health’: how psychological care can make a difference. Med J Aust 2016;205:104–6.
Buchanan J, Wordsworth S & Schuh A. Patients’ preferences for genomic diagnostic testing in chronic lymphocytic leukaemia: a discrete choice experiment. Patient 2016;9:525–36.
Kasparian NA, Lieu N, Winlaw DS, Cole A, Kirk E & Sholler GF. eHealth literacy and preferences for eHealth resources in parents of children with complex CHD. Cardiol Young 2017;27:722–30.
Caleshu C, Kasparian NA, Edwards KS et al. Interdisciplinary psychosocial care for families with inherited cardiovascular diseases. Trends Cardiovasc Med 2016;26:647–53.